The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors-Reference-Cited by-同舟云学术

The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors

Published:2023-12 Issue: Volume:20 Page:100408
ISSN:2590-0188
Container-title:Immuno-Oncology and Technology
language:en
Short-container-title:Immuno-Oncology and Technology

Author:

Boutros A.^ORCID,Carosio R.^ORCID,Campanella D.,Spagnolo F.^ORCID,Banelli B.,Morabito A.,Pistillo M.P.,Croce E.^ORCID,Cecchi F.,Pronzato P.,Queirolo P.,Raposio E.^ORCID,Fontana V.,Tanda E.T.

Publisher

Elsevier BV

Subject

Oncology,Immunology and Allergy

Reference34 articles.

1. Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032);Patel;Eur J Cancer,2011

2. Long-term survival in advanced melanoma for patients treated with nivolumab plus ipilimumab in CheckMate 067;Hodi;J Clin Oncol,2022

3. Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial;Hodi;Lancet Oncol,2016

4. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N Engl J Med,2011

5. Five-year outcomes with nivolumab in patients with wild-type BRAF advanced melanoma;Robert;J Clin Oncol,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma;Archives of Dermatological Research;2024-06-16